He may not be as well-known as Warren Buffett, but Peter Lynch is often referred to as a legendary investor for good reason.
The Fidelity Magellan Fund which he managed from 1977 to 1990 averaged an annual return of 29% during his tenure thanks largely to his investing strategy. Rather than focus on blue-chip shares like Woolworths Group Ltd (ASX: WOW), Lynch would focus on relatively undiscovered small-cap shares with explosive growth prospects.
Whilst we can only dream of making an average annual return of that level, I do believe that there are many small cap shares on the Australian share market that would suit Mr Lynch's criteria.
I've picked out three small caps which I feel could have bright futures:
Alcidion Group Ltd (ASX: ALC)
The first small cap to look at is Alcidion. It is a fast-growing informatics solutions company looking to take advantage of the technological changes that are taking place in the healthcare sector. It provides high quality software which aims to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. I believe the company is well placed for growth over the next decade thanks to the growing trend for healthcare organisations to shift to a paperless environment.
Bubs Australia Ltd (ASX: BUB)
Bubs is a goats milk focused infant formula and baby food company. It has been growing at a very strong rate in recent years thanks to increasing demand from the China market. And while its operations have been making a loss for some time, they finally appear to have reached the scale required to become profitable. In the third quarter of FY 2020 Bubs posted a 67% jump in quarterly revenue to $19.7 million and positive operating cashflow of $2.3 million. If it can build on this in the fourth quarter and into FY 2021, then Bubs could be destined for big things.
Serko Ltd (ASX: SKO)
Serko is a technology company focused on innovative solutions that address the challenges of corporate travel and expense management. It has been growing at a very strong rate over the last couple of years thanks to the increasing popularity of its Zeno product. Being in the travel industry the company is of course being negatively impacted by lockdowns and travel restrictions and its growth has come to a grinding halt. However, I remain confident it will bounce back strongly once conditions ease. So with its shares down almost 60% from their 52-week highs, now could be an opportune time to invest.
